Biotech China 2014

View Profile


Speaking/Presenting-Abstract/Poster at Mtg

Topic Authors / presenters Event name Event date
1. The RV in Left Heart Failure In ACC Symposium entitled Pulmonary Hypertension in LV Failure scheduled to start Apr 4 2011 10:45AM. American College of Cardiology Meeting 2010, New Orleans, LA. April, 2011
2. The Nuts and Bolts of Managing Patients with Pulmonary Hypertension American College of Cardiology Meeting 2010, New Orleans, LA. April, 2011
3. Diagnostic Tools for the Assessment of Pulmonary Hypertension: What Every Pulmonologist Needs To Know. Plenary PresentationEchocardiographic Concepts for the Pulmonologist American College of Chest Physicians Meeting, November 4, 2010. November, 2010
4. Common Decisions in the Adult Patient with Congenital Heart Disease.New Therapies for Pulmonary Hypertension. American Heart Association Scientific Sessions, Nov 14th, 2010. November, 2010
5. High Risk Patient Populations: PAH screening, diagnosis, and treatmen Cardiometabolic Health Congress, October 23rd 2010, Boston MA. October, 2010
6. Differences in accuracy of Doppler-estimated pulmonary vascular resistance relate to the degree of left atrial pressure contribution to pulmonary hypertension Anthony F Yu, MD, Yan Wang, MD, Lucas Marzec, MD, James N Kirkpatrick, MD, and Paul R Forfia, MD Heart Failure Society Meeting, September 2010. September, 2010
7. Tips and Pearls in Pulmonary Hypertension. Hemodynamic assessment of PH: echocardiography vs. catheterization 14th annual Heart Failure Society Meeting, Sep. 12th, 2010. September, 2010
8. RV Physiology and Response to Pulmonary Vascular Disease in Humans; considering the RV-PA interaction Alfred P. Fishman 1st Annual Alfred P. Fishman Symposium on Right Ventricular Structure and Function in Health and Disease. April 10, 2010. University of Pennsylvania June, 2010
9. Overview of pulmonary hypertension. Pathophysiologic basis of disease assessment and treatment. Cardiology Grand Rounds. Dartmouth- Hitchcock Medical Center. June 4th, 2010. June, 2010
10. Pathophysiologic basis of disease assessment and treatment in pulmonary hypertension-Considering the RV-PA interaction Northwestern University Hospital June, 2010
11. Pulmonary Hypertension. Noninvasive differentiation of ‘left vs. right’ sided causes…moving from pressure to pathophysiology Echo Update 2010. June 5th, 2010. Canadian Heart Research Centre and St. Michael’s Hospital, University of Toronto June, 2010
12. Treatment goals in Pulmonary Arterial Hypertension; targets and tactics for optimal care. Rounding with the experts, Case Presentation. Pulmonary Hypertension associated with Left Heart Diastolic Dysfunction Evening symposia at ACC 2010, March 15t March, 2010
13. The Common and the Complex in Pulmonary Hypertension American College of Cardiology Annual Scientific Sessions, March 14th, 2010 March, 2010
14. Tips and Pearls: Cardiology for the Clinician. Heart Failure Challenges; Echo vs. Cath in separating the right from the left. Evening symposia at ACC 2010, March 14th March, 2010
15. Cardiac Echocardiography for Pulmonary Hypertension 7th Annual Update in Pulmonary Hypertension. Tufts University School of Medicine. December 4th, 2009, Cambridge Mass. December, 2009
16. Noninvasive Approaches to RV function and Failure; implications for early diagnosis and phenotyping in PAH. Cardiology Grand Rounds, University of California, Davis. 11.20.09. November, 2009
17. Echo-Doppler scoring system provides simple noninvasive assessment of the pathophysiology of pulmonary hypertension in a mixed pulmonary hypertension cohort V. Prasanna MD, A. Opotowsky MD , J. Ojeda MD , J. Arkles MD, and P. Forfia, MD. American College of Chest Physicians Meeting, October 2009. October, 2009
18. Controversies in Pulmonary Hypertension: Exercise-Induced? Borderline Disease? Borderline Pulmonary Arterial Hypertension Is an Important and Useful Concept. American College of Chest Physicians Meeting, October 2009. October, 2009
19. Low dose nesiritide infusion leads to rapid and sustained improvement in renal function in patients with acute renal failure early post cardiac transplantation Heart Failure Society Meeting, September 2009. Stephen M Chrzanowski, MD, Christopher Wolfe, MSPAS,PA-C, Mariell L Jessup, MD, Michael A Acker, MD, Joyce W Wald, DO and Paul R Forfia, MD. September, 2009
20. Challenges and Controversies in Heart Failure: Echo vs. Cath: seperating the right from the left. Satellite Symposium, 13th annual Heart Failure Society Meeting, Sep. 13th, 2009. September, 2009
21. Serial Changes in TAPSE Correlate with Functional Assessment and Clinical Events in Patients with PAH A Basil, MD, T Liu, MD, J Arkles, MD, A Opotowsky, MD, D Taichman, MD, H I Palevsky, MD and P R Forfia, MD. American Thoracic Society Meeting, May 2009. May, 2009
22. Noninvasive Approaches to RV function and Failure; implications for early diagnosis and phenotyping in PAH. Morning conference, Tufts New England Medical Center, 5.8.09. May, 2009
23. Pulmonary Hypertension in Heart Failure; Treating a needle in a haystack, or not? Cardiology noon conference, Massachusetts General Hospital 5.7.09. May, 2009
24. Midsystolic notching of the pulmonary artery Doppler flow profile identifies pulmonary vascular disease and RV dysfunction in a mixed PH cohort A R Opotowsky, MD, J Arkles, MD, T Liu, MD, J Ojeda, MD, J Chirinos, MD, D Taichman, MD, H I Palevsky, MD and P R Forfia, MD. American Thoracic Society Meeting, May 2009. May, 2009
25. Pulmonary Hypertension. American College of Cadiology Annual Scientific Sessions, March, 2009. March, 2009
26. Pulmonary Hypertension for the Cardiologist; Summary of the ACC/AHA Clinical Expert Consensus Statement. American College of Cadiology Annual Scientific Sessions, 2009. January, 2009
27. Noninvasive Approaches to RV function and failure; implications for early diagnosis and phenotyping in PAH. Cardiology Grand Rounds, Stanford University 12.19.08. December, 2008
28. Noninvasive Approaches to RV function and failure; implications for early diagnosis and phenotyping in PAH. Cardiology Grand Rounds, Washington University/Barnes Jewish Hospital 12.17.08. December, 2008
29. Pulmonary Hypertension in Respiratory Disease; the cardiopulmonary interaction and its implications for patient phenotyping Pulmonary Grand Rounds, Stanford University 12.19.08. December, 2008
30. Hyponatremia reflects neurohormonal activation in patients with pulmonary arterial hypertension. Kristen Hyland, MD, Alix Morse, MD, Shiv Kapoor, PhD, Darren B. Taichman, MD, PhD, Harold I. Palevsky, MD and Paul R. Forfia, MD. Heart Failure Society Meeting, September 2008. September, 2008
31. Relative Dissociation Between Sympathetic and Natriuretic Peptide System Activation in Patients with Pulmonary Arterial Hypertension K.A. Hyland, C.L. Archer-Chicko, F.A. Rogers, S.C. Mathai, D.B. Taichman, H.I. Palevsky, and P.R. Forfia. American Thoracic Society Ineternational Meeting, May 2008. May, 2008
32. Why and how the right ventricle fails: characteristics of RV failure in various disease states. University of Pennsylvania, Cardiology Grand Rounds 5.6.08 May, 2008
33. Pulmonary Hypertension in Mixed Disease States. When to treat and why University of Pennsylvania, Medicine Grand Rounds, 5.4.08 May, 2008
34. Longitudinal Shortening Accounts for the Majority of Overall Right Ventricular Function in Normal Subjects and in PAH; Determination of a Normal Reference Range for TAPSE Suzanne B Brown, David Katz, Molly Szerlip, Susan E Wiegers, MD and Paul R Forfia. American Thoracic Society Ineternational Meeting, May 2008. May, 2008
35. Systolic Blood Pressure Response to Valsalva is a Simple Bedside Tool for Estimating Pulmonary Capillary Wedge Pressure in Patients with Pulmonary Hypertension. FA Rogers and PR Forfia American Thoracic Society Ineternational Meeting, May 2008. May, 2008
36. Ventilatory inefficiency is associated with right ventricular dysfunction in patients with an advanced cardiomyopathy. Mini-oral presentation and poster display. Methvin, A and Paul R. Forfia International Society for Heart and Lung Transplantation Meeting, April 2008. April, 2008
37. Why and how the right ventricle fails: characteristics of RV failure in various disease states. Christiana Medical Center, Cardiology Grand Rounds 2.22.08 February, 2008
38. Update on Management and Treatment of Pulmonary Arterial Hypertension; pearls and pitfalls in patient assessment Medicine Grand Rounds, Brooklyn Hospital Center, 2.12.08 February, 2008
39. Pulmonary Hypertension in Left Heart Disease; when is PH a ‘marker’ and when is it a ‘disease’? Cardiology Grand Rounds, New York Hospital Queens 2.13.08. February, 2008
40. Echocardiographic Assessment of Right Ventricular Function; the triad of RV failure. American Thoracic Society International Conference, 2008. January, 2008
41. Noninvasive Approaches to RV function and Failure; implications for early diagnosis and phenotyping in PAH Lecture to Cardiology Faculty, University of Michigan 8.08. January, 2008
42. Vasodilators in Acute Decompensated Heart Failure; when are inotropes really indicated? Cardiology Grand Rounds, Easton Hospital 9.27.07. September, 2007
43. Chronic PDE5 inhibition Attenuates Heart Failure Decompensation and Enhances the Renal Effects of Exogenous BNP in Canine Heart Failure Paul R. Forfia, Mudd J, Champion HC, and David A. Kass. Heart Failure Society of America Meeting, Fall 2007. April, 2007
44. Update on Atrial fibrillation, Update on Congestive Heart Failure, Update on Infectious Endocarditis, Update on Dyslipidemia American College of Physicians International Update Mexico City, March 9-10, 2007 March, 2007



Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation Event Month, Year
Breakfast Symposia - The Evolving Role of Endothelin Receptor Antagonists in PAH Management: Opportunities for Optimizing Patient Care and Outcomes 2010 Cardiometabolic Health Congress October, 2010

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.